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Ethnopharmacological  relevance:  Brazilian  folk  medicine  uses  infusion  of  Costus  spiralis  leaf  to  help  people
to  treat  arterial  hypertension  and  syndromes  of  cardiac  hyperexcitability.
Aim  of  the  study:  Evaluate  the  aqueous  fraction  (AqF)  effect  on  atrial  contractility  and  investigate  its
mechanism  of  action.
Materials  and methods:  The  AqF  effect  on  the  cardiac  contractility  was  studied  on isolated  electrically
driven  guinea  pig  left  atria.  Atropine  and  tetraethylammonium  (TEA)  were  employed  to investigate
whether  potassium  contributes  for  the  inotropic  mechanism  of  the AqF.  The  role  of  calcium  in  this  effect
was also  studied.  This  was  done  by analysing  the  AqF  effect  on  the  Bowditch’s  phenomenon,  as  well
as  by  studying  whether  it could  interfere  with  the  concentration–effect  curve  for  CaCl2, isoproterenol,
and  BAY  K8644.  Mice  isolated  cardiomyocytes  were  submitted  to  a whole-cell  patch-clamp  technique
in  order  to  evaluate  whether  the  L-type  calcium  current  participates  on the  AqF  effect.  Furthermore,  the
intracellular  calcium  transient  was  studied  by confocal  ﬂuorescence  microscopy.
Results: AqF  depressed  the  atrial  contractile  force.  It was  the  most  potent  fraction  from  C.  spiralis
leaf  (EC50 =  305  ±  41  mg/l)  (crude  extract:  EC50 = 712  ± 41; ethyl  acetate:  EC50 =  788  ±  121;  chloroform:
EC50 =  8948  ±  1346  mg/l).  Sodium  and  potassium  content  in  the  AqF  was  0.15  mM  and  1.91 mM,  respec-
tively.  Phytochemical  analysis  revealed  phenols,  tannins,  ﬂavones,  xanthones,  ﬂavonoids,  ﬂavonols,
ﬂavononols,  ﬂavonones,  and  saponins.  Experiments  with  atropine  and  TEA  showed  that  potassium  does
not participate  of  the  inotropic  mechanism  of  AqF.  However,  this  fraction  decreased  the force  overshoot
characteristic  of  the  Bowditch’s  phenomenon,  and  shifted  the  concentration–response  curve  for  CaCl2
(EC50 from  1.12  ±  0.07  to 7.23  ±  0.47  mM)  indicating  that  calcium  currents  participate  on  its mechanism
of  action.  Results  obtained  with  isoproterenol  (1–1000  pM)  and  BAY K8644  (5–2000  nM)  showed  that
AqF  abolished  the  inotropic  effect  of these  substances.  On  cardiomyocytes,  48  mg/l  AqF  reduced  (∼23%)
the L-type  calcium  current  density  from  −6.3 ± 0.3  to −4.9 ±  0.2  A/F  (n  = 5  cells,  p <  0.05)  and  reduced
the  intracellular  calcium  transient  (∼20%,  4.7  ±  1.2 a.u.,  n = 42  cells  to 3.7 ± 1.00 a.u.,  n  = 35 cells, p <  0.05).
However,  the  decay  time  of  the  ﬂuorescence  was  not  changed  (control:  860 ± 32  ms, n  = 42  cells;  AqF:
876  ±  26  ms,  n  =  35  cells,  p >  0.05).
Conclusions:  The  AqF  of  C.  spiralis  leaf  depresses  myocardial  contractility  by  reducing  the  L-type  calcium
current  and  by  decreasing  the  intracellular  calcium  transient.  Despite  the  lack  of  data  on  the  therapeutic
dose  of AqF  used  in  folk  medicine,  our  results  support,  at least  in part,  the  traditional  use  of  this  plant  to
treat  cardiac  disorders.
© 2011 Elsevier Ireland Ltd. 
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. Introduction
Costus spiralis (Jacq.) Roscoe, a member of the Zingiberaceae
amily, is commonly found in South American countries. In the
razilian Amazon, the popular name for C. spiralis is Cana-do-Brejo.
hytochemical analysis has revealed the presence of saponins (Da
ilva and Parente, 2004) and ﬂavonoids (Antunes et al., 2000). Fur-
hermore, the presence of inulin, oxalic acid, tannins, systosterol,
apogenins, mucilage, and pectin has been noted by Albuquerque
1989),  Corrêa et al. (1998),  and Vieira and Albuquerque (1998).
n the methanolic fraction Braga et al. (2007) reported the follow-
ng constituents: ﬂavonoids, esteroids, and alkaloids. C. spiralis has
een used as an ornamental plant and employed in folk medicine
Di Stasi and Hiruma-Lima, 2002; Araújo and Oliveira, 2007) to treat
ypertension and renal dysfunction and as a diuretic agent (Cruz,
982; Di Stasi and Hiruma-Lima, 2002). The antiurolithiatic activ-
ty of this plant was conﬁrmed by Viel et al. (1999),  corroborating
ts traditional use. Furthermore, its use as an antimicrobial, anti-
ungic, and antioxidant (Habsah et al., 2000; Braga et al., 2007)
gent, as well as its antileishmanial, cytotoxic, antiinﬂammatory,
nd immunomodulatory activity (Whittle, 1964; Silvia et al., 2000;
ilvia and Parente, 2003) has been reported in the literature. Pio-
orrêa (1984) also described the utility of C. spiralis juice in the
reatment of tachycardia. Kistler and Obeyesekere (2007) observed
hat this kind of arrhythmia increases the likelihood of myocardial
nfarction, heart failure, and cardiac strokes. Generically, tachycar-
ias are classiﬁed as ventricular or supraventricular, both of which
ave tremendous clinical relevance.
Supraventricular tachycardias, such as those due to atrial ﬁbril-
ation are commonly seen in medical practice. In most instances,
trial reentry mechanisms, often involving the atrioventricular
ode, are essential for sustaining the abnormal rhythm (Lee et al.,
008; Medi et al., 2009). Although a relatively large number of
rugs, such as the Ca2+-channel antagonists, are used to treat
upraventricular tachycardias, the pharmacological management
f this condition is still very complicated, mainly due to undesir-
ble drug side effects. Because C. spiralis is a plant traditionally used
o treat tachycardias, we decided to determine if its use in folk
edicine could be scientiﬁcally supported. Therefore, we  began
y investigating whether fractions obtained from a crude extract
f the C. spiralis leaf can alter mammalian atrial contractility. Fur-
hermore, our work provided new insights into the functional and
ellular mechanisms of the aqueous fraction in heart muscle.
. Materials and methods
.1. Fractions
Leaves from C. spiralis were collected from a healthy and
grotoxic-free plant (10◦56′42.14′′S, 37◦03′09.17′′O, Aracaju, State
f Sergipe, Brazil) during the winter season (June, 2009). Botan-
cal identiﬁcation was performed by Dr. Maria Olivia de Oliveira
ano of the Herbarium of Instituto Agronômico de Pernambuco
Dárdano de Andrade Lima”, where a voucher specimen was
eposited (#70.285). Leaves were gently cleaned, washed, and
ried (48 ± 2 ◦C, 8 days) before being subjected to maceration in
 water:ethanol solution (1:1, v:v, 27 ± 2 ◦C, for 15 days). The sol-
ents were evaporated in a Soxhlet apparatus (Laborota 4000,
eidolph, UK) and the hydroethanolic extract, designated as crude
xtract (CEx), was stored at −21 ◦C. From 222.30 g of dry leaves, we
btained 23.40 g of CEx (10.50%). Then 7.65 g of CEx were subjected
o liquid–liquid partition employing three solvents, chloroform
ChloF), ethyl acetate (EtAF), and water (AqF), to give the follow-
ng yields: 130.08 mg  (1.70%), 469.41 mg  (6.14%), and 5309.13 mg
69.40%), respectively. The solvents were evaporated (50 ± 2 ◦C),
nd all fractions were stored at −21 ◦C prior to use.rmacology 138 (2011) 382– 389 383
2.2. Chemical analysis of C. spiralis aqueous fraction
Sodium and potassium content of the AqF was determined by
ﬂame photometry (Digimed DM 61, São Paulo, SP, Brazil). The main
classes of secondary metabolites were determined using the Matos
protocol (1997).
2.3. Animals
Animals were handled according to procedures set forth by
the National Council of Control of Animal Experimentation (CON-
CEA/MCT, Brazil). The animal protocol was  previously approved
(Protocol #038/2008) by the Ethical Committee on Animal Research
of the Federal University of Sergipe. Guinea pigs of both sexes
(300–500 g) were supplied by the animal care unit of the Fed-
eral University of Sergipe. Intracellular calcium transients, as well
as measurements of the calcium inward current, were performed
on isolated cardiomyocytes from male C57BL6/J mice weighting
approximately 30 g. The experiments were approved by the Ethical
Committee on Research of the Federal University of Minas Gerais
(Protocol #236/2009).
2.4. Drugs
Reserpine, (−) BAY K8644 (1,4-dihydro-2-6-dimethyl-5-nitro-
4-[2-(triﬂuoromethyl)-phenyl]-3-pyridine acid carboxylic methyl
ester), isoproterenol, atropine, tetraethylammonium chloride
(TEA-Cl), EGTA, HEPES, cesium chloride (CsCl), barium chloride
(BaCl2), cesium hydroxide (CsOH), protease type XXIII, porcine
trypsin, lactic acid, pyruvic acid, and DMEM (“Dulbecco’s Mod-
iﬁed Eagle’s Medium”) were purchased from Sigma-Aldrich (St.
Louis, MO,  USA), and collagenase type II was  purchased from Wor-
thington Biochemical Corporation (Freehold, NJ, USA). Heparin was
purchased from ROCHE (Rio de Janeiro, RJ, Brazil), and Fluo-4 AM
was  purchased from Molecular Probes (Eugene, OR, USA).
2.5. Atrial contractility
Guinea pig atria were isolated, mounted in an organ chamber
(5 ml,  29 ± 0.1 ◦C), and superfused with modiﬁed Tyrode’s solution
(pH 7.12) gassed with carbogen (Dorigo et al., 1990; Vasconcelos
et al., 2005). The inotropic effects of CEx and its subfractions
were determined by adding them cumulatively to the organ bath.
The atria were electrically driven by ﬁeld stimulation employing
suprathreshold pulses of 0.5 ms.
2.6. Evaluation of the effect of AqF on calcium entry in
myocardial cells
2.6.1. Evaluation using the Bowditch maneuver
The positive staircase phenomenon described by Bowditch
(1871) is characterized by an increase in the amplitude of myocar-
dial contractile force following a sudden increase in the stimulation
rate. This is due to an increase in calcium entry into myocardial
cells, as demonstrated by Nayler and Merrillees (1971).  To imple-
ment the experimental protocol used by these authors, guinea pigs
were injected with reserpine (5 mg/kg, via i.p.) 24 h prior to the
experiments. Brieﬂy, the protocol was  as follows: (1) the atrium
was  stimulated at a very low rate (0.2 Hz, control stimulation) until
contractile force reached a steady-state; (2) then suprathreshold
stimuli were abruptly applied to overdrive the myocardial tissue at
various test rates; this procedure unbalanced the atrium and caused
the myocardial tissue to develop additional contractile force. The
test rate was  maintained for 150 s. Then stimulation was  paused
for 40 s before returning to the control rate. The applied test rates
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ere (Hz) 0.33, 0.50, 0.66, 1.00, 1.33, 1.66, 2.00, 2.50, and 3.33. To
tudy the effect of the most potent fraction on calcium entry into
yocardial cells, the Nayler and Merrillees protocol was performed
efore and after exposing the atrium to the aqueous fraction of C.
piralis.
.6.2. Evaluation using CaCl2, isoproterenol, and (−) BAY K8644
To study the effect of the most potent fraction of C. spiralis on
yocardial contractility, experimental maneuvers were performed
o increase the calcium inward current. This was achieved by expos-
ng the atrium to different calcium concentrations, or by adding
soproterenol or (−) BAY K8644 to the organ bath. In each case,
oncentration–response curves were obtained before and after
ncubating the atrium with the most potent fraction of C. spiralis.
.7. Cardiomyocyte isolation
Ventricular cardiomyocytes from mice (C57BL6/J) were enzy-
atically isolated as previously described by Shioya (2007).
.8. L-type calcium current measurements
Whole-cell voltage-clamp recordings were obtained at room
emperature (22–25 ◦C) using an EPC-9.2 patch clamp ampliﬁer
HEKA Electronics, Rheinland-Pfalz, Germany) as has been previ-
usly described (Lauton-Santos et al., 2007; Oliveira et al., 2007;
oman-Campos et al., 2009; Lara et al., 2010). For ICa,L mea-
urements, recording pipettes were ﬁlled with internal solution
ontaining (in mM)  5 NaCl, 120 CsCl, 20 TEA-Cl, 5 EGTA, and 10
EPES (pH set to 7.2 with CsOH). ICa,L was recorded in the presence
f 1.8 mM  extracellular Ca2+ (external solution).
For the time-course analysis of the effect of the most potent C.
piralis fraction on the L-type Ca2+ channels, ICa,L was  elicited every
0 s by test pulses generated from a holding potential of −80 mV  to
40 mV  for 50 ms  to inactivate the Na+ and T-type Ca2+ channels.
hen we stepped up the membrane potential to 0 mV for 200 ms.
his protocol was repeated before, during, and after washing out
he most potent fraction. Data are presented as current density
ICa,L/C, where C is the cell capacitance).
.9. Sarcoplasmic calcium removal
Myoplasmic calcium removal occurring after development
f the peak twitch contractile force was evaluated using the
onde-Garcia equation, F(i) = ((100 − Fmin)/Ki) + Fmin, where F(i)
s the amplitude of the ith contraction after a pause; Fmin
s the minimal amplitude of the post-pause contractions; and
 is the decay time-constant for the post-pause contractions.
his equation was employed to ﬁt the atrial twitch con-
ractions obtained after the pause in stimulation (Nayler and
errillees, 1971). The Conde-Garcia equation when expressed
s log(F(i) − Fmin) = log(100 − Fmin) − i log(K) results in a straight
ine described by an equation of the type Y = B − Ax,  where
 = log(F(i) − Fmin), B = log(100 − Fmin), A = log K, and X = i. A is the
lope of the straight line and represents the decay rate during the
ost-pause phase. We  interpret this parameter as a descriptor of
he calcium removal rate from the sarcoplasm, a phenomenon that
s associated with the myocardial relaxation phase.
.10. Intracellular calcium transientIsolated cardiomyocytes obtained from mouse ventricles were
oaded with 5 M Fluo-4 AM (stock solution prepared in pure
imethyl-sulfoxide – DMSO) for 30 minutes at room temperature
nd then washed with extracellular solution containing 1.8 mMrmacology 138 (2011) 382– 389
Ca2+ to remove the excess of dye (Lauton-Santos et al., 2007). Car-
diac cells were exposed to the most potent C. spiralis fraction for
3 min. Then Ca2+ transients were elicited by electrical ﬁeld stim-
ulation applied to the cardiomyocytes through a pair of platinum
electrodes. Suprathreshold square pulses of 0.2 ms  duration were
continuously applied at 1 Hz. A Meta LSM 510 scanning system
(Zeiss GmbH, Jena, Germany) with a 63× oil immersion objective
and 10× ocular was  used for confocal ﬂuorescence imaging with
a total magniﬁcation of 630×. Fluo-4 AM was  excited at 488 nm
(Argon laser), and the emission intensity was measured at 510 nm.
For recording Ca2+ transients, myocytes were scanned with a 512
pixel line. The scan line was  positioned randomly along the longitu-
dinal axis of the cell, although care was taken to avoid crossing the
nuclei. Cells were scanned every 1.54 ms, and sequential scans were
stacked to create two-dimensional images with time on the x-axis.
Digital image processing was  performed using a custom-designed
routine in the IDL programming language (Research Systems, Boul-
der, CO). The intracellular Ca2+ levels were reported as F/F0, where
F0 is the resting Ca2+ ﬂuorescence.
2.11. Statistical analysis
Data are reported as the mean ± S.E.M. Figures were created in
GraphPad Prism (GraphPad Software, CA, USA), Excel (Microsoft
Ofﬁce, USA), or SigmaPlot (Systat Software, IL, USA). Mean val-
ues were compared using the paired Student’s t-test or one-way
ANOVA. p < 0.05 was used as the criterion for statistical signiﬁcance.
3. Results
3.1. Effect of C. spiralis fractions on atrial contractility
CEx and the other C. spiralis fractions depressed atrial contractil-
ity in a concentration-dependent manner. However, the potencies
of the various fractions, as estimated by EC50, were not equal.
Fig. 1(A–D) shows representative recordings of the effect pro-
duced by C. spiralis fractions on atrial contractile force. Fig. 1E
summarizes those effects. The following EC50 values were found:
305 ± 41 mg/l for AqF, 712 ± 41 mg/l for CEx, 788 ± 121 mg/l for
EtAF, and 8948 ± 1346 mg/l for ChloF. Although all C. spiralis frac-
tions produced a negative inotropic effect, the AqF was the most
potent. For this reason, it was  used in the experiments subsequently
carried out to evaluate the inotropic mechanism of C. spiralis in
heart muscle.
We  also investigated whether muscarinic receptors participate
in the negative inotropic effect of C. spiralis AqF. Experiments were
performed using atrial tissue pre-incubated with atropine (1.5 M),
a non-selective antagonist of muscarinic receptors. The presence
of atropine did not alter the pharmacological effects of AqF (data
not shown). The participation of membrane potassium channels in
the cardiodepressor effect of C. spiralis was  also investigated using
TEA (20 mM),  a nonspeciﬁc potassium channel blocker. In the pres-
ence of TEA, the negative inotropic effect of AqF was  not modiﬁed.
Thus, we  may  conclude that C. spiralis reduces cardiac contractility
through a mechanism that does not involve potassium channels or
the activation of cardiac muscarinic receptors.
3.2. Ionic and phytochemical content
The sodium and potassium content in 1 g/l of AqF, as deter-
mined by ﬂame spectrometry, were 0.15 and 1.91 mM,  respectively.
These concentrations were not sufﬁcient to produce an inotropic
effect, even at the highest AqF concentration used in this study. The
main classes of secondary metabolites present in AqF were phenols,
R.M. Britto et al. / Journal of Ethnopharmacology 138 (2011) 382– 389 385
Fig. 1. Representative recordings showing the effect of C. spiralis leaf fractions on atrial contractile force (A, B, C, D) and concentration–response curves comparing the
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annins, ﬂavones, xanthones, ﬂavonoids, ﬂavonols, ﬂavononols,
avonones, and saponins.
.3. Effects of the aqueous fraction of C. spiralis on sarcolemmal
alcium inﬂux
The amount of calcium entering cardiomyocytes via the sar-
olemma is a very important factor contributing to control of
yocardial contractile force (Bers, 2008). To determine whether
qF modiﬁes calcium inﬂux, the experiments described in the next
ubsections were performed.
.3.1. Bowditch phenomenon
The positive staircase phenomenon previously described by
owditch (1871) is characterized by an increase in the amplitude of
yocardial twitch contractions following a sudden increase in the
timulation rate. It was later demonstrated by several authors that
his increase in contractile force is due to an increase in calcium
ntry into myocardial cells (Nayler and Merrillees, 1971; Endoh,
004; Monasky and Jansen, 2009). In Fig. 2A, the additional force
i.e., the force overshoot) is plotted against the rate of stimulation.
e can see that when the stimulation rate was gradually increased
rom 20 to 120 bpm, the overshoot of force increased continuously.
lthough this occurred in the control and washout conditions, the
orce overshoot was abolished when the atrium was incubated with
500 mg/l AqF. This result suggests that AqF from C. spiralis acts by
educing calcium inﬂux in cardiac muscle.
.3.2. Evaluation by varying the external calcium concentration
Several experimental protocols were performed to test the
ffect of AqF on the calcium inward current. For us, this is the pri-
ary event supporting evidence for the negative inotropic effect
f AqF in the myocardium. First, we followed a very straightfor-
ard protocol in which the extracellular calcium concentration was
hanged in the absence and in the presence of 1500 mg/l AqF.
Fig. 2C shows the positive inotropic effect of increases in
xtracellular calcium concentration. The EC50 for CaCl2 wasoints were ﬁtted by the Hill–Langmuir equation. AqF was the most potent fraction
◦C; ﬁeld stimulation, 2 Hz, suprathreshold pulses, 0.5 ms; n = 3).
1.12 ± 0.07 mM.  However, when the atria were pre-incubated with
1500 mg/l AqF, the concentration–response curve shifted to the
right, and the EC50 increased to 7.23 ± 0.47 mM (approximately
6 fold, p < 0.05). These data conﬁrm that the cardiac effects of C.
spiralis AqF are associated, at least in part, with a decrease in sar-
colemmal calcium inﬂux.
3.3.3. Evaluation using isoproterenol or (−) BAY K8644
It is well established that calcium inﬂux in cardiac cells occurs
by activation of both L-type (LCC) and T-type calcium channels
(TCC) (Bers, 2008). To determine whether LCCs are involved in the
cardiodepressor effect of AqF, we performed experiments using
standard drugs to evoke positive inotropic responses by directly
[(−) BAY K8644] or indirectly (isoproterenol) activating LCC. Cumu-
lative addition of these drugs to the organ bath caused a positive
inotropic effect on the myocardium (Fig. 2B and D). The EC50 calcu-
lated for isoproterenol and (−) BAY K8644 was  11.2 ± 1.2 pM and
77.2 ± 1.1 nM (p < 0.05), respectively. The positive inotropic effect
of both isoproterenol and (−) BAY K8644 was completely abolished
by the addition of 1500 mg/l AqF to the bath. Our ﬁndings suggest
that the C. spiralis AqF reduces the L-type calcium is reduced by the
C. spiralis AqF.
3.3.4. Evaluation using direct measurement of L-type calcium
current
Further evidence indicating that AqF reduces the L-type calcium
current in myocardial cells was obtained using the patch-clamp
technique. Fig. 3A shows the time course of the effect of 48 mg/l AqF
on L-type calcium current density in ventricular myocytes evoked
at a rate of 0.1 Hz by depolarizing pulses to 0 mV from a hold-
ing potential of −80 mV.  Our results showed that AqF reduced (by
∼23%) the current density from −6.6 to −5.1 A/F, and the effect of
AqF was  partially reversible. Fig. 3B shows representative traces of
the L-type calcium current obtained at the indicated time points in
Fig. 3A. The recordings shown were obtained under control condi-
tions (black trace), in 48 mg/l AqF (blue trace), and during washout
(red trace). Fig. 3C summarizes the effect of AqF (48 mg/l) on the
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ffect of both isoproterenol (B) and BAY K8644 (D). AqF also caused a rightward shi
-type calcium current density; this fraction signiﬁcantly reduced
he L-type calcium current density from −6.3 ± 0.3 to −4.9 ± 0.2 A/F
n = 5, p < 0.05). Taken together, our results support the hypothesis
hat the reduction in cardiac contractile force promoted by the AqF
s indeed a consequence of its inhibitory effect on L-type calcium
hannels.
ig. 3. C. spiralis AqF reduces L-type calcium current density in isolated mouse cardiomy
n  control solution (black circle), in AqF (blue circle), and after washout (red circle). Pan
8  mg/l AqF, and after washout. Panel C: L-type calcium current density measured at 0 mV
p  < 0.05; 29 ± 2 ◦C).tion completely abolished the Bowditch phenomenon (A), and the positive inotropic
e concentration–response curve for CaCl2 (C) (n = 4; *p < 0.05; 29 ± 0.1 ◦C).
3.4. Effects of the aqueous fraction of C. spiralis on the global
intracellular calcium transientIt is well established that intracellular [Ca2+] handling is critical
for controlling cardiac contractility (Bers, 2008) and is also linked
to arrhythmogenic mechanisms in the heart (Wang and Goldhaber,
ocytes. Panel A: Time course of the calcium current (expressed as current density)
el B: calcium current traces obtained under control conditions, in the presence of
 under control conditions and in the presence of 48 mg/l AqF (n = 5 cells; 5 animals;
R.M. Britto et al. / Journal of Ethnopharmacology 138 (2011) 382– 389 387
Fig. 4. Effect of AqF (48 mg/l) on the peak amplitude of the intracellular calcium
transient and on the ﬂuorescence decay time. Representative recordings of the
intracellular calcium transient are seen in panels A and B. Panel A: pseudocolor
representation of the intracellular calcium levels in the control and after 48 mg/l
AqF. Panel B: reduction in the peak ﬂuorescence after addition of 48 mg/l AqF to the
external medium. Panels C and D: effect of AqF on the peak ﬂuorescence signal and
o
n
2
t
g
t
i
s
a
s
f
F
i
s
i
c
l
p
t
r
C
t
l
3
t
n
b
(
p
Fig. 5. Decay rate of the envelope of post-pause contractions, as measured with the
duration and membrane hyperpolarization. In addition, stimula-n  the decay phase (at 90%) obtained in a group of cells (control, n = 42 cells; AqF,
 = 35 cells; 4 animals; *p < 0.05; ﬁeld stimulation, suprathreshold pulses, 1 Hz).
004). Because AqF induces a negative inotropic effect by inhibiting
he L-type calcium current, we decided to investigate whether the
lobal intracellular calcium transient was also affected by that frac-
ion. Fig. 4A shows on a pseudocolor scale, the temporal changes
n the intracellular calcium concentration observed in electrically
timulated cardiomyocytes. Data were obtained before (control)
nd after incubation of the cell with 48 mg/l AqF. The pseudocolor
cale shows the range of the intracellular calcium concentration
rom low (blue) to high (red). The ﬂuorescence was  expressed as
/F0, where F0 is the ﬂuorescence during the resting state and F
s the maximal ﬂuorescence measured after the delivery of the
timulus. As can be seen, the red color distribution was  dimin-
shed in the presence of AqF, indicating a reduction in intracellular
alcium levels. Fig. 4B depicts the original recordings of the intracel-
ular calcium transient. In these traces, the peaks (arrow in the left
anel) represent the highest level of intracellular calcium, whereas
he decay phase (arrow in right panel) is associated with calcium
emoval from the sarcoplasm. This event reﬂects the activity of the
a-ATPase of the sarcoplasmic reticulum (SERCA). Fig. 4C shows
hat AqF signiﬁcantly changed the peak amplitude of the intracel-
ular calcium transient, reducing it from 4.7 ± 1.2 (control, n = 42) to
.7 ± 1.00 a.u. (AqF, n = 35, p < 0.05), a decrease of ∼20%. In spite of
hat effect, the decay phase was unchanged, indicating that AqF did
ot alter the activity of the SERCA pump (Fig. 4D). The average time
etween peak ﬂuorescence and 90% decay (T90) was  860 ± 32 ms
n = 42) in control and 876 ± 26 ms  in the presence of AqF (n = 35,
 > 0.05).aid  of the Conde-Garcia equation. Angular coefﬁcients were the same for the straight
lines obtained in the control () and after adding AqF to the bath ()  (n = 4; p > 0.05;
29.0  ± 0.1 ◦C; Field stimulation: suprathreshold pulses, 0.5 ms, 0.2 Hz).
If the AqF does not affect SERCA activity, as suggested by the
intracellular ﬂuorescence signal, then the decay rate of the enve-
lope of post-pause twitch contractions, as seen with the Nayler and
Merrillees protocol, should not be affected by AqF. To evaluate this
hypothesis, we analyzed the results obtained with that protocol
using the Conde-Garcia equation. Fig. 5 depicts the results obtained
before and after atrial incubation with AqF. Because the slope
(angular coefﬁcient) of both straight lines are the same, it is rea-
sonable to conclude that these results corroborate those obtained
with intracellular ﬂuorescence.
In conclusion, the reduction in L-type calcium current was
accompanied by a decrease in the global intracellular calcium tran-
sient without signiﬁcant alterations in the kinetics of sarcoplasmic
calcium removal. Therefore, our ﬁndings provide strong evidence
to explain how the cardiodepressor effect of C. spiralis AqF occurs.
4. Discussion
In the present study, we have demonstrated that fractions
obtained from the C. spiralis leaf promote a concentration-
dependent cardiodepressor effect on the mammalian myocardium.
The ﬁrst step taken to better understand their contractile effect was
to determine the most potent fraction. To do this, we  compared the
inotropic effects of the crude hydroethanol extract with those of the
following fractions: ethyl acetate, chloroform, and water. All frac-
tions depressed atrial contractility in a concentration-dependent
fashion. However, the AqF exhibited the greatest potency. This sug-
gests that the cardioactive compound(s) present in the AqF must
be highly polar. The negative inotropic effect of the C. spiralis frac-
tions and the comparatively high potency of AqF accord with the
traditional use of this medicinal plant, wherein infusions and juices
from its leaves are known to be prepared in water to treat patients
suffering cardiac hyperexcitability syndromes.
Phytochemical screening performed on the AqF revealed the
presence of the following classes of secondary metabolites:
ﬂavonoids, xanthones, and tannins. Its sodium and potassium
content, however, was  very low. At the highest concentration
employed in this study, the AqF changed the extracellular sodium
concentration from 120 to 120.15 mM  and the potassium concen-
tration from 1.91 to 4.61 mM.  These maximal concentrations were
insufﬁcient to modify any of the atrial contractility parameters, as
previously shown by our group (Vasconcelos et al., 2005).
It is well known that the activation of muscarinic M2 receptors
in atrial muscle causes an increase in the acetylcholine-sensitive
potassium current leading to a reduction in action potentialtion of M2 receptors also inhibits membrane adenylate cyclase,
which causes augmentation of the intracellular cyclic AMP  level.
These cellular effects contribute to the classical inotropic negative
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esponse evoked by muscarinic agonists, principally through the
eduction of calcium inward current (Dhein et al., 2001). Based on
ur results, we can rule out the possibility of muscarinic receptors
nd/or potassium channels mediating the cardiodepressor effect of
. spiralis AqF because incubation of the preparations with atropine,
 non-selective muscarinic antagonist, or TEA, a nonspeciﬁc potas-
ium channel blocker, did not modify the myocardial effects of C.
piralis fractions.
C. spiralis is a plant traditionally used to treat hypertension
nd disturbances in cardiac rhythm. Curiously, these clinical dys-
unctions involve changes in the intracellular calcium signaling
ascades (Tostes and Wilde, 1997; Lompré, 1999; Wang and
oldhaber, 2004; Schotten et al., 2011). Calcium is ubiquitous
n the regulation of cardiac excitation–contraction coupling. Fur-
hermore, a vast number of other cellular functions have been
ttributed to this important second messenger. The initiation of
ardiac excitation–contraction coupling occurs when an action
otential is generated and propagated. This event depolarizes the
embrane and activates voltage dependent L-type calcium chan-
els (LCCs). As a consequence, extracellular calcium enters the cells
ollowing its electrochemical gradient, an event that stimulates
he release of calcium stored in the sarcoplasmic reticulum (SR)
hrough a process known as “calcium-induced calcium release”
CICR). Calcium entry via LCCs and calcium release from the SR
ogether lead to a subsequent rise of the sarcoplasmic calcium
oncentration ([Ca2+]i) to values close to 1 M,  allowing calcium
inding to troponin C. The latter event activates the contractile
achinery to produce contraction. For the purpose of promoting
elaxation, [Ca2+]i must return to its resting levels (∼100–150 nM).
n this process, two transporters are relevant: SERCA – pumping
a2+ back to the SR – and the Na–Ca2+ exchanger (NCX) – extrud-
ng Ca2+ into the extracellular medium (Bers, 2002, 2008). It is
mportant to mention that insufﬁcient calcium inﬂux leads to an
nefﬁcient cardiac contraction. On the other hand, excessive cal-
ium entry should evoke cell death, contracture and generation of
athological membrane currents (Wang and Goldhaber, 2004). For
hese reasons, the cardiomyocytes have several control points to
aintain calcium homeostasis. Among them, the SERCA and LCC
ctivity are signiﬁcant because in adult cardiomyocytes LCC is the
rimary route for calcium entry into the cell and SERCA is the most
elevant mechanism that reduces [Ca2+]i by promoting calcium re-
ptake into the SR lumen (Bers, 2002). Our data provide indirect
nd direct evidence that the AqF of C. spiralis reduces calcium inﬂux
y blocking LCCs. Because the SR calcium load available for CICR
epends on the amount of calcium that enters the cell through acti-
ated LCCs, the inhibitory action of AqF would result in a reduction
f the global intracellular calcium transient, as we  observed in this
tudy. Furthermore, these observations at the functional and cellu-
ar levels could account for the cardiodepressor effect of C. spiralis
n atrial muscle.
Abnormal calcium signaling is involved in the electrogene-
is of cardiac arrhythmias. Calcium-mediated arrhythmias can be
bserved during digitalis toxicity that occurs under conditions
f intracellular calcium overload (Clusin, 2003). In this situation,
he intracellular sodium concentration rises and the sodium is
xchanged for extracellular calcium. The [Ca2+]i overload results
n spontaneous SR calcium release by ryanodine receptor (RyR)
ctivation, thereby generating a depolarizing inward current
hrough NCX. This event causes delayed after depolarizations
DADs) and is responsible for the triggered arrhythmias commonly
ound in heart failure. Another source of triggered arrhythmias
s early after depolarizations (EADs). In this case, arrhythmia is
aused by prolongation of the action potential, an event that results
n an excessive inward calcium current during each cardiac cycle
Wang and Goldhaber, 2004; Schotten et al., 2011). Thus, the mech-
nisms involved in intracellular calcium handling represent anrmacology 138 (2011) 382– 389
interesting target for antiarrhythmic drugs. Here we  demonstrated
that C. spiralis is able to modify calcium handling through a
reduction in sarcolemmal calcium inward current, which at least
in theory, would render the cardiomyocytes less susceptible to
arrhythmias. Thus, our present ﬁndings support the popular use
of teas and infusions obtained from this plant as antiarrhyth-
mic  agents. Moreover, we showed that C. spiralis blocks L-type
calcium channels that are an important molecular target in con-
ventional pharmacotherapy of hypertension, a pathology for which
C. spiralis is also traditionally used. Although the empirical use
of C. spiralis does, in fact, have a rationale, it is quite important
to highlight the need for further chemical studies and in vivo
toxicological/pharmacological evaluations of the plant extract to
determine its therapeutic efﬁcacy and safety.
5. Conclusions
C. spiralis leaf fractions depress myocardial contractility. The car-
dioactive compound must be of high polarity because the aqueous
fraction, obtained from the crude hydroethanolic extract, was the
most potent in reducing atrial contractile force. Its effect does not
involve any potassium-linked cellular mechanisms. However, the
AqF reduced the L-type calcium current. Despite the lack of quanti-
tative data in the literature about the therapeutic dose of C. spiralis
when used in folk medicine, our ﬁndings support the use of this
plant when prescribed for the treatment of arterial hypertension
or disturbances of the cardiac rhythm.
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